UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_______________________



FORM 8-K



_______________________



CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934



Date of report (Date of earliest event reported): October 19, 2006



IMCLONE SYSTEMS INCORPORATED

(Exact Name of Registrant as Specified in Charter)



|Delaware
      (State or other jurisdiction 
      of Incorporation) | 0-19612
        (Commission File 
        Number) | 04-2834797
      (IRS Employer 
      Identification No.)
|-------------------------------------------------------------------- | ------------------------------------------------- | ---------------------------------------------------------





180 Varick StreetNew York, New York            10014

(Address of principal executive offices)         (Zip Code)



(212) 645-1405

(Registrant's telephone number, including area code)



N/A

(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))







| |  | 
| |  | 





---









Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.



(d)
        On October 19, 2006, Peter S. Liebert, M.D. was named a director of ImClone Systems Incorporated (the Company). The text of the related press release, which is attached as Exhibit 99.1, is incorporated by reference herein in its entirety.




Item 8.01. Other Events.



Also on October 19, 2006, the Board appointed David Sidransky, M.D. as a member of the Compensation Committee and Carl C. Icahn as chairman of the Chief Executive Officer Search Committee.  As a result, (1) the Compensation Committee consists of Mr. Miller and Drs. Denner and Sidransky (chaired by Mr. Miller) and (2) the Chief Executive Officer Search Committee consists of Messrs. Icahn and Miller and Drs. Denner, DeVita and Sidransky (chaired by Mr. Icahn).



Item 9.01.  Financial Statements and Exhibits.





ExhibitNumber
      Description
        ________________________________________________________________________________________________________________________________99.1
        Text of press release issued by the Company, dated October 20, 2006, entitled ImClone Systems Appoints Peter S. Liebert, M.D., to Board of Directors (filed herewith)


















2






---





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



IMCLONE SYSTEMS INCORPORATEDDate: October 20, 2006
        By:
        /s/ Daniel J. OConnor
             Daniel J. OConnor 
             Vice President, Interim General Counsel


















3






---



EXHIBIT INDEX






ExhibitNumber
      Description
________________________________________________________________________________________________________________________________99.1
        Text of press release issued by the Company, dated October 20, 2006, entitled ImClone Systems Appoints Peter S. Liebert, M.D., to Board of Directors (filed herewith)






4